13th Mar 2026 11:00
Modulight Corporation | Company Release | March 13, 2026 at 13:00:00 EET
Modulight’s Annual Report 2025 has been published today. The Annual Report includes the financial statements, the Board of Directors’ Report and sustainability information. In addition, Modulight has published the Corporate Governance Statement and the Remuneration Report. All materials have been published in Finnish and English.The Annual Report, the Corporate Governance Statement and the Remuneration Report are attached to this release and available at https://modulight.com/reports-presentations/.
For further information, please contact:
CEO Seppo Orsila, m. +358 40 830 4671IR Ulla Haapanen, m. +358 40 830 4676Email: [email protected]
Certified adviser: Sisu Partners Oy, m. +358 40 555 4727 modulight.com@modulight
Modulight in brief
Modulight Corporation is a life science company that designs and manufactures laser devices for the treatment of cancer and eye diseases. The company also manufactures products for other high value-add applications including flow cytometry, microscopy, semiconductor, quantum, and defense. The company’s products include medical devices, subsystems, software, cloud services, and specialized semiconductors. Modulight’s products are used worldwide by many Fortune 500 companies, pharmaceutical companies, and well-known cancer centers and universities. Modulight was founded in 2000 and is headquartered in Tampere, Finland.
Follow Modulight: modulight.com | X | LinkedIn | Facebook | YouTube | Instagram | #KillCancer
Attachments
Modulight Annual Report 2025Modulight CG Statement 2025Modulight Remuneration Report 2025